C Boulos et al, 2019. Nutritional Risk Factors, Microbiota and Parkinson's Disease: What Is the Current Evidence, Nutrients, Volume 11 (8).
M A Kromhout et al, 2019. Caffeine and neuropsychiatric symptoms in patients with dementia: a systematic review, Experimental Gerontology, published online.
S C Larsson and N Orsini, 2018. Coffee Consumption and Risk of Dementia and Alzheimer's Disease: A Dose-response Meta-Analysis of Prospective Studies, Nutrients, Volume 10 (10).
A Hussain et al, 2018. Caffeine: a potential protective agent against cognitive decline in Alzheimer’s disease, Critical Review in Eukaryiotic Gene Expression, Volume 28 (1).
B H Cho et al, 2018. Association of Coffee Drinking and Non-motor Symptoms in Drug Naive, Early Stage Parkinson's Disease, Parkinsonism and Related Disorders, published online.
I Y Kim et al, 2018. Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2) on Parkinson's disease risk. Movement Disorders, published online.
M Fujimaki et al, 2018. Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease, Neurology, published online.
S C Larsson et al, 2017. Modifiable pathways in Alzheimer' s disease: Mendelian randomisation analysis, British Medical Journal, published online.
I Y Kim et al, 2017. Differences in Parkinson's Disease Risk with Caffeine Intake and Postmenopausal Hormone Use, Journal of Parkinson's Disease, published online.
R Wierzejska, 2017. Can coffee consumption lower the risk of Alzheimer's disease and Parkinson's disease? A literature review, Archives of Medical Science, Volume 13 (3)
This information is intended for Healthcare professional audiences.
Please consider the environment before printing.